title: Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis.
authors.affiliation: St. Barnabas Medical Center, Livingston, New Jersey, USA. nkramer@sbhcs.com
authors.forename: Neil
authors.initials: N
authors.lastname: Kramer
authors.forename: Yelena
authors.initials: Y
authors.lastname: Chuzhin
authors.forename: Lee D
authors.initials: LD
authors.lastname: Kaufman
authors.forename: Jill M
authors.initials: JM
authors.lastname: Ritter
authors.forename: Elliot D
authors.initials: ED
authors.lastname: Rosenstein
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged; D011014:Pneumonia / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab; D008727:Methotrexate